Arthur H Briggs

Title: The Innovative Contributions of Arthur H. Briggs

Introduction

Arthur H. Briggs is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of anti-craving compositions, particularly in relation to alcohol consumption. His work focuses on the inhibition of the breakdown of endogenous substances, which has implications for addiction treatment.

Latest Patents

Arthur H. Briggs holds a patent for "Enkephalinase and endorphinase inhibitors as anti-craving compositions." This patent introduces a new class of anti-craving compositions that utilize substances to inhibit the breakdown of enkephalins and endorphins. The research indicates that these inhibitors can effectively reduce alcohol cravings, as demonstrated in both animal and human studies. Specifically, compounds such as D-phenylalanine, DL-phenylalanine, D-leucine, DL-leucine, and hydrocinnamic acid have shown promise in lowering alcohol intake, particularly in genetically predisposed individuals.

Career Highlights

Throughout his career, Arthur H. Briggs has focused on innovative solutions to combat addiction. His research has contributed to a deeper understanding of how endogenous substances can be leveraged to influence cravings and behaviors related to substance use. His work is recognized for its potential impact on public health and addiction treatment strategies.

Collaborations

Arthur H. Briggs has collaborated with notable figures in the field, including Kenneth J. Blum and Jack E. Wallace. These collaborations have enriched his research and expanded the scope of his work in addiction science.

Conclusion

Arthur H. Briggs is a pioneering inventor whose work on anti-craving compositions has the potential to transform addiction treatment. His innovative approach to utilizing enkephalin and endorphin inhibitors marks a significant advancement in the field.